Intrinsic Value of S&P & Nasdaq Contact Us

CEL-SCI Corporation CVM NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
60/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

CEL-SCI Corporation (CVM) has a negative trailing P/E of -1.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -73.34%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -73.34% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 58/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
60/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
80/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — CVM

Valuation Multiples
P/E (TTM)-1.4
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.91
P/S Ratio0.00
EV/EBITDA-1.7
Per Share Data
EPS (TTM)$-2.97
Book Value / Share$1.39
Revenue / Share$0.00
FCF / Share$-2.12
Yields & Fair Value
Earnings Yield-73.34%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -4.4 0.06 -53.30 178.78 -
2017 0.0 0.00 -0.16 7.59 -
2018 -0.1 -0.03 3,163.29 6.08 -
2019 -14.8 0.15 71.19 789.79 -
2020 -17.5 -0.79 28.51 1,006.70 -
2021 -13.7 -1.51 9.49 0.00 -
2022 -4.2 0.57 4.97 0.00 -
2023 -2.1 0.11 5.05 0.00 -
2024 -2.8 0.07 5.90 0.00 -
2025 -1.5 0.03 2.34 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-2.36 $285.06K $-11.47M -4022.6%
2017 $-1.82 $69.02K $-14.36M -20810.3%
2018 $-1.87 $476.56K $-31.84M -6680.7%
2019 $-0.79 $462.75K $-24.69M -5336%
2020 $-0.88 $558.66K $-32.22M -5767.9%
2021 $-0.96 $0.00 $-39.19M -
2022 $-0.89 $0.00 $-38.27M -
2023 $-0.73 $0.00 $-32.37M -
2024 $-0.51 $0.00 $-26.92M -
2025 $-6.27 $0.00 $-25.41M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-4.16 $-4.16 – $-4.16 $4.69M $4.69M – $4.69M 1
2027 $-0.92 $-0.92 – $-0.92 $18.98M $18.98M – $18.98M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message